We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
D icon
326
Dominion Energy
D
$62.2B
$4.93M 0.05%
+60,777
New +$4.87M
KPTI icon
327
Karyopharm Therapeutics
KPTI
$154M
$4.91M 0.05%
17,298
-39,060
-69% -$11.6M
DELL icon
328
Dell
DELL
$239B
$4.91M 0.05%
176,266
+150,445
+583% +$3.38M
PBA icon
329
Pembina Pipeline
PBA
$29.2B
$4.86M 0.05%
194,969
+21,672
+13% +$501K
COP icon
330
ConocoPhillips
COP
$144B
$4.85M 0.05%
115,510
-4,325
-4% -$175K
DPZ icon
331
Domino's
DPZ
$12B
$4.83M 0.05%
13,078
+10,171
+350% +$3.75M
PVH icon
332
PVH
PVH
$3.99B
$4.81M 0.05%
100,129
-30,918
-24% -$1.44M
BIDU icon
333
Baidu
BIDU
$35.6B
$4.8M 0.05%
40,028
-145,429
-78% -$15.6M
ADVM
334
DELISTED
Adverum Biotechnologies
ADVM
$4.77M 0.05%
22,858
+2,858
+14% +$506K
ACIA
335
DELISTED
Acacia Communications Inc
ACIA
$4.73M 0.05%
+70,341
New +$4.77M
MCO icon
336
Moody's
MCO
$84.4B
$4.67M 0.05%
16,978
+535
+3% +$136K
DGX icon
337
Quest Diagnostics
DGX
$26B
$4.65M 0.05%
40,833
+6,553
+19% +$695K
RY icon
338
Royal Bank of Canada
RY
$288B
$4.63M 0.05%
68,512
+2,240
+3% +$142K
MU icon
339
Micron Technology
MU
$874B
$4.63M 0.05%
89,907
-18,455
-17% -$870K
ED icon
340
Consolidated Edison
ED
$41.4B
$4.61M 0.05%
64,110
-97,133
-60% -$7.46M
MFC icon
341
Manulife Financial
MFC
$73.1B
$4.61M 0.05%
339,821
+43,940
+15% +$553K
LOGM
342
DELISTED
LogMein, Inc.
LOGM
$4.6M 0.05%
+54,213
New +$4.6M
MYOV
343
DELISTED
Myovant Sciences Ltd.
MYOV
$4.57M 0.05%
221,403
+97,742
+79% +$1.33M
DRI icon
344
Darden Restaurants
DRI
$24.3B
$4.54M 0.05%
59,854
-60,504
-50% -$4.29M
NGM
345
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.52M 0.05%
228,764
-13,236
-5% -$253K
GE icon
346
GE Aerospace
GE
$365B
$4.48M 0.05%
131,657
-19,748
-13% -$666K
HIG icon
347
Hartford Financial Services
HIG
$39.7B
$4.42M 0.05%
114,716
-88,852
-44% -$3.39M
ZTS icon
348
Zoetis
ZTS
$32.9B
$4.42M 0.05%
32,245
-10,137
-24% -$1.32M
BAX icon
349
Baxter International
BAX
$12.6B
$4.42M 0.05%
51,314
-7,833
-13% -$682K
TGT icon
350
Target
TGT
$66.7B
$4.41M 0.05%
36,766
-52,763
-59% -$6.02M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.